肿瘤指南

订阅

MedSci主页 / 所有栏目 / 肿瘤指南

2021 ESMO临床实践指南：小细胞肺癌的诊断，治疗和随访

2021-04-19 欧洲肿瘤内科学会 Ann Oncol

肺癌小细胞肺癌

2021年4月，欧洲肿瘤内科学会(ESMO)发布了小细胞肺癌的诊断，治疗和随访指南。本文主要针对小细胞肺癌的管理提供指导建议，内容涉及诊断，治疗和随访。

中文标题：

2021 ESMO临床实践指南：小细胞肺癌的诊断，治疗和随访

英文标题：

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

发布机构：

欧洲肿瘤内科学会

发布日期：

2021-04-19

简要介绍：

2021年4月，欧洲肿瘤内科学会(ESMO)发布了小细胞肺癌的诊断，治疗和随访指南。本文主要针对小细胞肺癌的管理提供指导建议，内容涉及诊断，治疗和随访。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ESMO临床实践指南：小细胞肺癌的诊断，治疗和随访.pdf)] GetToolGuiderByIdResponse(projectId=1, id=10f961c00230619a, title=2021 ESMO临床实践指南：小细胞肺癌的诊断，治疗和随访, enTitle=Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, guiderFrom=Ann Oncol, authorId=0, author=, summary=2021年4月，欧洲肿瘤内科学会(ESMO)发布了小细胞肺癌的诊断，治疗和随访指南。本文主要针对小细胞肺癌的管理提供指导建议，内容涉及诊断，治疗和随访。, cover=https://img.medsci.cn/20211228/1640672899391_5579292.jpg, journalId=0, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会（ESMO，European Society for Medical Oncology )是1975年成立的非盈利组织，是欧洲领先的专业组织，致力于提高肿瘤内科的专业性，推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Mon Apr 19 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年4月，欧洲肿瘤内科学会(ESMO)发布了小细胞肺癌的诊断，治疗和随访指南。本文主要针对小细胞肺癌的管理提供指导建议，内容涉及诊断，治疗和随访。</span></p>, tagList=[TagDto(tagId=428, tagName=肺癌), TagDto(tagId=1165, tagName=小细胞肺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1165, guiderKeyword=小细胞肺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2236, appHits=295, showAppHits=0, pcHits=614, showPcHits=1939, likes=0, shares=45, comments=9, approvalStatus=1, publishedTime=Tue Dec 28 14:26:40 CST 2021, publishedTimeString=2021-04-19, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Dec 28 14:34:18 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 16:23:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ESMO临床实践指南：小细胞肺癌的诊断，治疗和随访.pdf)])
2021 ESMO临床实践指南：小细胞肺癌的诊断，治疗和随访.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1208582, encodeId=29061208582dd, content=好资源，学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:42:27 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200643, encodeId=cb3c120064318, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Tue Mar 08 19:28:53 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196186, encodeId=11941196186b6, content=学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39415160640, createdName=146b6cbem78暂无昵称, createdTime=Tue Feb 22 19:46:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186096, encodeId=63b611860960b, content=小细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Wed Jan 19 18:19:07 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185248, encodeId=4873118524820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Mon Jan 17 17:05:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-04-04 ms3000000771933475

    好资源，学习！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1208582, encodeId=29061208582dd, content=好资源，学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:42:27 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200643, encodeId=cb3c120064318, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Tue Mar 08 19:28:53 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196186, encodeId=11941196186b6, content=学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39415160640, createdName=146b6cbem78暂无昵称, createdTime=Tue Feb 22 19:46:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186096, encodeId=63b611860960b, content=小细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Wed Jan 19 18:19:07 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185248, encodeId=4873118524820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Mon Jan 17 17:05:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-03-08 ms3000000190198551

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1208582, encodeId=29061208582dd, content=好资源，学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:42:27 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200643, encodeId=cb3c120064318, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Tue Mar 08 19:28:53 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196186, encodeId=11941196186b6, content=学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39415160640, createdName=146b6cbem78暂无昵称, createdTime=Tue Feb 22 19:46:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186096, encodeId=63b611860960b, content=小细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Wed Jan 19 18:19:07 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185248, encodeId=4873118524820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Mon Jan 17 17:05:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-02-22 146b6cbem78暂无昵称

    学习谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1208582, encodeId=29061208582dd, content=好资源，学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:42:27 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200643, encodeId=cb3c120064318, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Tue Mar 08 19:28:53 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196186, encodeId=11941196186b6, content=学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39415160640, createdName=146b6cbem78暂无昵称, createdTime=Tue Feb 22 19:46:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186096, encodeId=63b611860960b, content=小细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Wed Jan 19 18:19:07 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185248, encodeId=4873118524820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Mon Jan 17 17:05:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-01-19 恒心

    小细胞

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1208582, encodeId=29061208582dd, content=好资源，学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:42:27 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200643, encodeId=cb3c120064318, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Tue Mar 08 19:28:53 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196186, encodeId=11941196186b6, content=学习谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39415160640, createdName=146b6cbem78暂无昵称, createdTime=Tue Feb 22 19:46:35 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186096, encodeId=63b611860960b, content=小细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Wed Jan 19 18:19:07 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185248, encodeId=4873118524820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Mon Jan 17 17:05:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-01-17 ms3000002057134316

    学习

    0

相关指南

2021 ESMO 临床实践指南的更新：早期和局部晚期非小细胞肺癌：侧重于诊断、分期、全身和局部治

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2021-09-01

中国非小细胞肺癌免疫检查点抑制剂治疗专家共识（2020年版）

国家癌症中心 · 2021-04-20

2021 加拿大共识建议：MET突变非小细胞肺癌的管理

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2021-11-09

肺癌中西医结合诊疗专家共识

广州中医药大学第一附属医院 · 2021-11-25

中国人群肺癌血清标志物临床应用及参考区间建立规范化流程专家共识

中国抗癌协会肿瘤标志专业委员会 · 2021-07-02

肿瘤突变负荷应用于肺癌免疫治疗的专家共识

中国临床肿瘤学会非小细胞肺癌专家委员会 · 2021-11-20

拓展阅读

2015 ASCO/ACCP：小细胞肺癌治疗指南

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2016-05-30

2018 CCO指南：小细胞肺癌的初期管理以及胸部放疗和一线化疗的作用

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2018-07-11

2020 ASTRO临床实践指南：小细胞肺癌放射治疗

美国放射治疗及肿瘤学会(ASTRO,American Society for Therapeutic Radiology and Oncology) · 2020-03-23

2020 ESTRO-ACROP指南：小细胞肺癌胸部放射治疗的靶区定义

欧洲放射肿瘤学学会(ESTRO,European Society of Radiotherapy & Oncology) · 2020-07-13

ASCO和ASTRO指南：小细胞肺癌的放疗

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2021-01-21

2022 NICE指南更新：肺癌的诊断和管理[NG122]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2022-09-22